Transparency
IVF Success Rates by Age
This page is a framework. Replace placeholder values with audited clinic data and publish a clear methodology.
Age-band overview
Fill the success rate column with the chosen primary metric. Consider adding cohort size and timeframe once audited.
| Age band | Success rate | Notes |
|---|---|---|
| <30 | — (Add %) | Placeholder band summary |
| 30–34 | — (Add %) | Placeholder band summary |
| 35–37 | — (Add %) | Placeholder band summary |
| 38–40 | — (Add %) | Placeholder band summary |
| 41–42 | — (Add %) | Placeholder band summary |
| 43+ | — (Add %) | Placeholder band summary |
Methodology disclaimer (keep this section when publishing)
- Success rates depend on age, diagnosis, ovarian reserve, sperm factors, embryo genetics, and treatment adherence.
- Any published number should specify timeframe, cohort size, and the exact metric definition.
- Individual outcomes vary; consult a fertility specialist for a personalized plan.
What the numbers should represent
Define the exact metric before publishing: clinical pregnancy rate, live birth rate, or ongoing pregnancy rate. Use one primary metric and mention secondary metrics separately.
How we segment outcomes
Most audited reporting groups outcomes by maternal age, diagnosis (PCOS, endometriosis, male factor), and whether embryos were tested (PGT-A).
Why outcomes vary
Embryo genetics, ovarian reserve, sperm quality, uterine factors, and protocol adherence are major drivers. Lab processes and clinical decision quality also matter.
Success rate FAQs
Are success rates the same as live birth rates?▾
Not always. A success rate can mean different things (clinical pregnancy, ongoing pregnancy, or live birth). This page should clearly define the metric used once final numbers are approved.
Can you publish success rates by diagnosis?▾
Yes. Many clinics publish segmented success rates (PCOS, tubal factor, male factor, endometriosis) as long as the cohort size is sufficient and the methodology is clearly stated.
Does PGT-A improve outcomes?▾
PGT-A can reduce transfers of aneuploid embryos and may improve time-to-pregnancy in select cohorts, but it is not right for everyone. The decision should be individualized.